about
Heparan Sulfate Proteoglycan Metabolism and the Fate of Grafted TissuesStructural and functional imaging in parkinsonian syndromes.Activation of mammalian Toll-like receptors by endogenous agonists.Multimodality Imaging of Neurodegenerative Processes: Part 2, Atypical Dementias.Multimodality Imaging of Neurodegenerative Processes: Part 1, The Basics and Common Dementias.Effect of patient age, breast density, and topical anesthetic cream on perceived pain with sentinel lymph node scintigraphy.Malignant involvement of the peripheral nervous system in patients with cancer: multimodality imaging and pathologic correlation.Future of thoracic PET scanning.Pulmonary nodule characterization, including computer analysis and quantitative features.ACR Appropriateness Criteria® acute respiratory illness in immunocompromised patients.Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis.Biphenotypic hepatic tumors: imaging findings and review of literature.ACR Appropriateness Criteria Review ACR Appropriateness Criteria® Occupational Lung Diseases.PET/MRI: Where might it replace PET/CT?Spectrum of Benign Articular and Periarticular Findings at FDG PET/CT.Stereotactic body radiation therapy of liver tumors: post-treatment appearances and evaluation of treatment response: a pictorial review.Imaging patterns and focal lesions in fatty liver: a pictorial review.Conditional signaling by Toll-like receptor 4.Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4.Comparison of facet joint activity on 99mTc-MDP SPECT/CT with facet joint signal change on MRI with fat suppression.Targeting B lymphocytes in progressive fibrosing mediastinitis.Percutaneous cryoablation of musculoskeletal oligometastatic disease for complete remission.A genetic basis for the "Adonis" phenotype of low adiposity and strong bones.Pulmonary fibrosis in dyskeratosis congenita: report of 2 cases.AJR teaching file: left neck mass evaluated by PET/CT.18F-Florbetapir and 18F-FDG PET/CT in Systemic Immunoglobulin Light Chain Amyloidosis Involving the Peripheral Nerves.Toll-like receptor-4 and allograft responses.Characterization of F-18 Fluorodeoxyglucose PET/CT in Granulomatosis with Polyangiitis.Pulmonary masses in a patient with dyspnea: Apply Occam's razor or Hickam's dictum?Multicenter Study of Planar Technetium 99m Pyrophosphate Cardiac Imaging: Predicting Survival for Patients With ATTR Cardiac Amyloidosis.Detection of ALECT2 amyloidosis by positron emission tomography-computed tomography imaging with florbetapir.Radiologic Response to Neoadjuvant Treatment Predicts Histologic Response in Thymic Epithelial Tumors.Evaluation of (18)F-FDG PET and MRI in differentiating benign and malignant peripheral nerve sheath tumors.Pseudomyxoma pleuri. A rare manifestation of an uncommon disease.Integrated Use of Perfusion SPECT/CTA Fusion Imaging and Pulmonary Balloon Angioplasty for Chronic Pulmonary Thromboembolism.Cutting edge: an endogenous pathway to systemic inflammatory response syndrome (SIRS)-like reactions through Toll-like receptor 4Tolerance and the microenvironmentBenign fibrous dysplasia on [(11)C]choline PET: a potential mimicker of disease in patients with biochemical recurrence of prostate cancerEndobronchial ultrasound and lymphoproliferative disorders: a retrospective studyUtility of baseline positron emission tomography with computed tomography for predicting endoscopic resectability and survival outcomes in patients with early esophageal adenocarcinoma
P50
Q26797410-A22CC38D-F1C0-4C16-B9EC-15DE17C41093Q35057021-4B5FC952-8A18-41BB-A316-985AD2024524Q35195062-E9A86150-74B4-4AD6-B1BB-EA9EE90DACBDQ36098473-BFF5523C-491B-4B9D-AD72-FA451C7521B3Q36099066-0011F5B7-BF4C-4BDE-A777-FE1415F06B5BQ37974172-EEA448F4-C770-42EA-9E4B-9A0CF887DA55Q38266596-1C1B0FC8-BCE5-48B9-8A07-8995FD84E9B4Q38308264-37EFE520-FECF-4294-93F5-5D377876E784Q38346596-4A1A220E-FD79-4296-8332-7269C8715522Q38402791-FD2C3C58-892D-425B-BF57-542197BE1E95Q38414834-96D4B4DC-B847-4191-AC1E-C4E3479B07E3Q38465673-733E8050-964F-4BB6-AB0B-8EB80D83A902Q38666071-6A1EB47D-DDFB-40A8-9CA1-7903882515F8Q38735917-64CCF990-8827-44CF-A7F3-916437EDD535Q38830876-83E6B80A-6903-4495-855C-F7A2CBD25E34Q38831804-4486AE3E-76BC-4D83-B565-993B4ABCEBB4Q39045054-CA2D8709-2EA7-4532-8C35-47A6BAA2CCE3Q40452634-9A629FFD-0F50-4477-A08D-E06AA158AFF9Q40733888-16F24FCB-63CA-444A-AA08-F7D7CA2E495EQ41129437-BA4B8DE7-8E4A-4A5C-AA27-8300C5162025Q42763843-0F9FD017-05ED-4EB6-B204-DD78CC9C3280Q44005902-145757E0-C02B-4121-8CB4-BCAE7DA8CDA8Q47316543-5CD8CD9E-649F-4A95-8663-BF3BD4AD9E1FQ48011566-AC843627-00A3-465F-8D1A-59EA3B5DE7CBQ48569205-87B44443-2036-4134-B859-80030462DF8EQ50865871-110380F4-FD99-4808-848C-421F9A3C4C06Q51034670-D4A453FB-1ACF-44A6-BFC6-637E9F39D7F8Q51549548-A8D9139C-C308-4331-86F8-EBC487C1FF84Q51692183-3216EA46-D699-40D9-8FF7-7B58E720EDACQ51839511-919957CA-1EBE-4B6C-825B-3A42A9BDC568Q52923362-D14F0312-9BAB-417E-8E9A-933184E9EE6BQ52966402-8B996E5C-4259-456C-93C5-6912D4608C65Q52983394-02CB6288-BEBD-4475-A170-8E9002918384Q53006018-0605CB87-CA63-42B9-80A6-58787BD317EEQ53790384-EB605975-899B-499F-9C83-143027A7F9D7Q75197360-BCD66480-A20F-42E2-A317-3EBBE14BEDD4Q77752306-52E0AD64-9C45-4F7C-BE6D-F8829C4ECED6Q84313045-8BFB6C4B-BA09-4D79-8658-1B6D9F8B10C5Q85237515-43AB6D66-A310-45FE-BCB5-AA08FBFAE24EQ86172380-5416FCDF-C692-466F-97CA-2F4FA69ACF68
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Geoffrey B Johnson
@ast
Geoffrey B Johnson
@en
Geoffrey B Johnson
@es
Geoffrey B Johnson
@nl
Geoffrey B Johnson
@sl
type
label
Geoffrey B Johnson
@ast
Geoffrey B Johnson
@en
Geoffrey B Johnson
@es
Geoffrey B Johnson
@nl
Geoffrey B Johnson
@sl
prefLabel
Geoffrey B Johnson
@ast
Geoffrey B Johnson
@en
Geoffrey B Johnson
@es
Geoffrey B Johnson
@nl
Geoffrey B Johnson
@sl
P106
P108
P21
P31
P496
0000-0002-4866-1401